vs
Idexx Laboratories（IDXX）与Sprouts Farmers Market, Inc.（SFM）财务数据对比。点击上方公司名可切换其他公司
Sprouts Farmers Market, Inc.的季度营收约是Idexx Laboratories的2.0倍（$2.1B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs 4.2%，领先18.6%），Idexx Laboratories同比增速更快（14.3% vs 7.6%），Idexx Laboratories自由现金流更多（$326.3M vs $66.3M），过去两年Sprouts Farmers Market, Inc.的营收复合增速更高（6.8% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
Sprouts Farmers Market是总部位于美国亚利桑那州凤凰城的连锁超市品牌，主营天然有机食品，涵盖新鲜果蔬、散装食品、包装杂货、肉禽海鲜、熟食烘焙、乳制品、冷冻食品等品类，同时售有维生素补剂、天然个护及家居用品，目前在全美24个州开设超400家门店，员工约3.5万名。
IDXX vs SFM — 直观对比
营收规模更大
SFM
是对方的2.0倍
$1.1B
营收增速更快
IDXX
高出6.6%
7.6%
净利率更高
IDXX
高出18.6%
4.2%
自由现金流更多
IDXX
多$260.0M
$66.3M
两年增速更快
SFM
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $2.1B |
| 净利润 | $248.2M | $89.8M |
| 毛利率 | 60.3% | 38.0% |
| 营业利润率 | 28.9% | 5.7% |
| 净利率 | 22.8% | 4.2% |
| 营收同比 | 14.3% | 7.6% |
| 净利润同比 | 14.8% | 12.8% |
| 每股收益（稀释后） | $3.09 | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXSFM
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.2B | ||
| Q2 25 | $1.1B | $2.2B | ||
| Q1 25 | $998.4M | $2.2B | ||
| Q4 24 | $954.3M | $2.0B | ||
| Q3 24 | $975.5M | $1.9B | ||
| Q2 24 | $1.0B | $1.9B | ||
| Q1 24 | $964.1M | $1.9B |
净利润IDXXSFM
| Q4 25 | $248.2M | $89.8M | ||
| Q3 25 | $274.6M | $120.1M | ||
| Q2 25 | $294.0M | $133.7M | ||
| Q1 25 | $242.7M | $180.0M | ||
| Q4 24 | $216.1M | $79.6M | ||
| Q3 24 | $232.8M | $91.6M | ||
| Q2 24 | $203.3M | $95.3M | ||
| Q1 24 | $235.6M | $114.1M |
毛利率IDXXSFM
| Q4 25 | 60.3% | 38.0% | ||
| Q3 25 | 61.8% | 38.7% | ||
| Q2 25 | 62.6% | 38.8% | ||
| Q1 25 | 62.4% | 39.6% | ||
| Q4 24 | 59.8% | 38.1% | ||
| Q3 24 | 61.1% | 38.1% | ||
| Q2 24 | 61.7% | 37.9% | ||
| Q1 24 | 61.5% | 38.3% |
营业利润率IDXXSFM
| Q4 25 | 28.9% | 5.7% | ||
| Q3 25 | 32.1% | 7.2% | ||
| Q2 25 | 33.6% | 8.1% | ||
| Q1 25 | 31.7% | 10.1% | ||
| Q4 24 | 27.4% | 5.3% | ||
| Q3 24 | 31.2% | 6.3% | ||
| Q2 24 | 26.3% | 6.7% | ||
| Q1 24 | 31.0% | 7.9% |
净利率IDXXSFM
| Q4 25 | 22.8% | 4.2% | ||
| Q3 25 | 24.8% | 5.5% | ||
| Q2 25 | 26.5% | 6.0% | ||
| Q1 25 | 24.3% | 8.0% | ||
| Q4 24 | 22.7% | 4.0% | ||
| Q3 24 | 23.9% | 4.7% | ||
| Q2 24 | 20.3% | 5.0% | ||
| Q1 24 | 24.4% | 6.1% |
每股收益（稀释后）IDXXSFM
| Q4 25 | $3.09 | $0.93 | ||
| Q3 25 | $3.40 | $1.22 | ||
| Q2 25 | $3.63 | $1.35 | ||
| Q1 25 | $2.96 | $1.81 | ||
| Q4 24 | $2.62 | $0.78 | ||
| Q3 24 | $2.80 | $0.91 | ||
| Q2 24 | $2.44 | $0.94 | ||
| Q1 24 | $2.81 | $1.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $257.3M |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $1.4B |
| 总资产 | $3.4B | $4.2B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXSFM
| Q4 25 | $180.1M | $257.3M | ||
| Q3 25 | $208.2M | $322.4M | ||
| Q2 25 | $164.6M | $261.4M | ||
| Q1 25 | $164.0M | $285.7M | ||
| Q4 24 | $288.3M | $265.2M | ||
| Q3 24 | $308.6M | $309.7M | ||
| Q2 24 | $401.6M | $177.3M | ||
| Q1 24 | $397.4M | $312.3M |
总债务IDXXSFM
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXSFM
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.2B |
总资产IDXXSFM
| Q4 25 | $3.4B | $4.2B | ||
| Q3 25 | $3.4B | $4.0B | ||
| Q2 25 | $3.3B | $3.8B | ||
| Q1 25 | $3.2B | $3.7B | ||
| Q4 24 | $3.3B | $3.6B | ||
| Q3 24 | $3.4B | $3.6B | ||
| Q2 24 | $3.4B | $3.4B | ||
| Q1 24 | $3.4B | $3.5B |
负债/权益比IDXXSFM
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $138.5M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $66.3M |
| 自由现金流率自由现金流/营收 | 29.9% | 3.1% |
| 资本支出强度资本支出/营收 | 2.7% | 3.4% |
| 现金转化率经营现金流/净利润 | 1.43× | 1.54× |
| 过去12个月自由现金流最近4个季度 | $1.1B | $467.7M |
8季度趋势，按日历期对齐
经营现金流IDXXSFM
| Q4 25 | $355.8M | $138.5M | ||
| Q3 25 | $402.3M | $167.1M | ||
| Q2 25 | $185.7M | $111.2M | ||
| Q1 25 | $238.0M | $299.1M | ||
| Q4 24 | $262.0M | $124.9M | ||
| Q3 24 | $220.1M | $209.1M | ||
| Q2 24 | $248.3M | $91.6M | ||
| Q1 24 | $198.6M | $219.7M |
自由现金流IDXXSFM
| Q4 25 | $326.3M | $66.3M | ||
| Q3 25 | $371.2M | $111.4M | ||
| Q2 25 | $151.6M | $50.4M | ||
| Q1 25 | $207.9M | $239.6M | ||
| Q4 24 | $232.8M | $56.2M | ||
| Q3 24 | $192.0M | $156.3M | ||
| Q2 24 | $215.0M | $33.9M | ||
| Q1 24 | $168.3M | $168.5M |
自由现金流率IDXXSFM
| Q4 25 | 29.9% | 3.1% | ||
| Q3 25 | 33.6% | 5.1% | ||
| Q2 25 | 13.7% | 2.3% | ||
| Q1 25 | 20.8% | 10.7% | ||
| Q4 24 | 24.4% | 2.8% | ||
| Q3 24 | 19.7% | 8.0% | ||
| Q2 24 | 21.4% | 1.8% | ||
| Q1 24 | 17.5% | 8.9% |
资本支出强度IDXXSFM
| Q4 25 | 2.7% | 3.4% | ||
| Q3 25 | 2.8% | 2.5% | ||
| Q2 25 | 3.1% | 2.7% | ||
| Q1 25 | 3.0% | 2.7% | ||
| Q4 24 | 3.1% | 3.4% | ||
| Q3 24 | 2.9% | 2.7% | ||
| Q2 24 | 3.3% | 3.0% | ||
| Q1 24 | 3.1% | 2.7% |
现金转化率IDXXSFM
| Q4 25 | 1.43× | 1.54× | ||
| Q3 25 | 1.47× | 1.39× | ||
| Q2 25 | 0.63× | 0.83× | ||
| Q1 25 | 0.98× | 1.66× | ||
| Q4 24 | 1.21× | 1.57× | ||
| Q3 24 | 0.95× | 2.28× | ||
| Q2 24 | 1.22× | 0.96× | ||
| Q1 24 | 0.84× | 1.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
SFM
| Perishables | $1.2B | 56% |
| Non Perishables | $935.4M | 44% |
